10. Segment and Geographic Information
|9 Months Ended|
Dec. 31, 2016
|Segment Reporting [Abstract]|
|Segment and Geographic Information||
The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.
The Company operates a single segment business for product revenues, which consists of three geographical sales territories as follows:
During the three and nine months ended December 31, 2016, the Company reported $465,000 of Latin America product revenue related to the Supply Agreement with Invekra.
In connection with the Company’s sale of its Latin American business to Invekra, product revenues were reclassified from continuing operations to discontinued operations as follows:
The following table shows the Company’s product license fees and royalties revenues by partner:
The Company’s service revenues amounted to $187,000 and $227,000 for the three months ended December 31, 2016 and 2015, respectively.
The Company’s service revenues amounted to $638,000 and $855,000 for the nine months ended December 31, 2016 and 2015, respectively.
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
Reference 1: http://www.xbrl.org/2003/role/presentationRef